Tamar Lasky

2.3k total citations · 1 hit paper
38 papers, 1.6k citations indexed

About

Tamar Lasky is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases and General Health Professions. According to data from OpenAlex, Tamar Lasky has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 8 papers in Infectious Diseases and 5 papers in General Health Professions. Recurrent topics in Tamar Lasky's work include Pharmaceutical studies and practices (9 papers), Pediatric Pain Management Techniques (4 papers) and Child and Adolescent Health (4 papers). Tamar Lasky is often cited by papers focused on Pharmaceutical studies and practices (9 papers), Pediatric Pain Management Techniques (4 papers) and Child and Adolescent Health (4 papers). Tamar Lasky collaborates with scholars based in United States, Netherlands and Canada. Tamar Lasky's co-authors include Noel S. Weiss, David S. Siscovick, Robert H. Fletcher, Paul D. Stolley, Laurence S. Magder, Michael Ballesteros, Lawrence B. Schonberger, Robert T. Chen, Shelley Clark and Penina Haber and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Annals of Internal Medicine.

In The Last Decade

Tamar Lasky

36 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Incidence of Primary Cardiac Arrest during Vigorous Exercise

1984 569 citations Tamar Lasky et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tamar Lasky United States	16	468	271	202	184	181	38	1.6k
Samad EJ Golzari Iran	26	213 0.5×	155 0.6×	205 1.0×	109 0.6×	104 0.6×	126	2.2k
Ali Kabir Iran	25	236 0.5×	177 0.7×	474 2.3×	53 0.3×	186 1.0×	139	2.2k
G. Grassi Italy	27	211 0.5×	117 0.4×	545 2.7×	92 0.5×	68 0.4×	144	2.6k
Simon Capewell United Kingdom	30	844 1.8×	148 0.5×	407 2.0×	115 0.6×	46 0.3×	93	2.8k
William J. Stone United States	31	301 0.6×	105 0.4×	264 1.3×	63 0.3×	119 0.7×	94	3.2k
Richard D. Shih United States	23	220 0.5×	86 0.3×	110 0.5×	71 0.4×	62 0.3×	112	1.5k
Semir Nouira Tunisia	25	560 1.2×	46 0.2×	337 1.7×	63 0.3×	95 0.5×	114	2.1k
Miguel C. Riella Brazil	34	323 0.7×	184 0.7×	367 1.8×	27 0.1×	68 0.4×	154	4.2k
Alexandre Braga Libório Brazil	26	160 0.3×	147 0.5×	394 2.0×	42 0.2×	58 0.3×	103	2.1k
Ferdinando Romano Italy	25	130 0.3×	276 1.0×	312 1.5×	57 0.3×	43 0.2×	118	2.3k

Countries citing papers authored by Tamar Lasky

Since Specialization

Citations

This map shows the geographic impact of Tamar Lasky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Lasky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Lasky more than expected).

Fields of papers citing papers by Tamar Lasky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamar Lasky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Lasky. The network helps show where Tamar Lasky may publish in the future.

Co-authorship network of co-authors of Tamar Lasky

This figure shows the co-authorship network connecting the top 25 collaborators of Tamar Lasky. A scholar is included among the top collaborators of Tamar Lasky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamar Lasky. Tamar Lasky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Nancy D., et al.. (2023). Considerations for defining medication exposure when analyzing real‐world data. Pharmacoepidemiology and Drug Safety. 32(8). 933–937. 1 indexed citations

Beebe, Elisha, Elizabeth M. Garry, Nicolle M. Gatto, et al.. (2023). A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022. Open Forum Infectious Diseases. 10(7). ofad339–ofad339. 1 indexed citations

Garry, Elizabeth M., Andrew R. Weckstein, Kenneth Quinto, et al.. (2022). Categorization of COVID‐19 severity to determine mortality risk. Pharmacoepidemiology and Drug Safety. 31(7). 721–728. 13 indexed citations

Lasky, Tamar, Bruce Carleton, Daniel B. Horton, et al.. (2020). Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review. Drugs - Real World Outcomes. 7(2). 97–107. 13 indexed citations

Lasky, Tamar, Frank R. Ernst, & Jay S. Greenspan. (2012). Use of Analgesic, Anesthetic, and Sedative Medications During Pediatric Hospitalizations in the United States 2008. Anesthesia & Analgesia. 115(5). 1155–1161. 13 indexed citations

Lasky, Tamar, Jay S. Greenspan, Frank R. Ernst, & Liliana González. (2012). Pediatric Vancomycin Use in 421 Hospitals in the United States, 2008. PLoS ONE. 7(8). e43258–e43258. 12 indexed citations

Lasky, Tamar, Jay S. Greenspan, Frank R. Ernst, & Liliana González. (2012). Morphine Use in Hospitalized Children in the United States: A Descriptive Analysis of Data From Pediatric Hospitalizations in 2008. Clinical Therapeutics. 34(3). 720–727. 8 indexed citations

Lasky, Tamar, Jay S. Greenspan, Frank R. Ernst, & Liliana González. (2011). Dopamine and Dobutamine Use in Preterm or Low Birth Weight Neonates in the Premier 2008 Database. Clinical Therapeutics. 33(12). 2082–2088. 17 indexed citations

Lasky, Tamar, Frank R. Ernst, Jay S. Greenspan, Shirley Wang, & Liliana González. (2010). Estimating pediatric inpatient medication use in the United States. Pharmacoepidemiology and Drug Safety. 20(1). 76–82. 31 indexed citations

10.

Lasky, Tamar. (2009). Estimates of pediatric medication use in the United States: Current abilities and limitations. Clinical Therapeutics. 31(2). 436–445. 22 indexed citations

11.

Koehler, Kathleen M., Tamar Lasky, Sara B. Fein, et al.. (2006). Population-Based Incidence of Infection With Selected Bacterial Enteric Pathogens in Children Younger Than Five Years of Age, 1996–1998. The Pediatric Infectious Disease Journal. 25(2). 129–134. 48 indexed citations

12.

Ward, Robert M., W.E. Benitz, Daniel K. Benjamin, et al.. (2006). Criteria supporting the study of drugs in the newborn. Clinical Therapeutics. 28(9). 1385–1398. 18 indexed citations

13.

Lasky, Tamar, et al.. (2003). Mean total arsenic concentrations in chicken 1989-2000 and estimated exposures for consumers of chicken.. Environmental Health Perspectives. 112(1). 18–21. 100 indexed citations

14.

Lasky, Tamar. (2002). Foodborne illness--old problem, new relevance.. PubMed. 13(5). 593–8. 4 indexed citations

15.

Smith, Renee, Kathleen Malee, Manhattan Charurat, et al.. (2000). Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Pediatric Infectious Disease Journal. 19(9). 862–871. 48 indexed citations

16.

Lasky, Tamar, Laurence S. Magder, Carol Lee Koski, et al.. (1998). The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines. New England Journal of Medicine. 339(25). 1797–1802. 357 indexed citations

17.

Lasky, Tamar & Laurence S. Magder. (1997). Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?. Environmental Health Perspectives. 105(4). 392–397. 30 indexed citations

18.

Lasky, Tamar & Ellen K. Silbergeld. (1996). P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.. Environmental Health Perspectives. 104(12). 1324–1331. 35 indexed citations

19.

Stolley, Paul D., et al.. (1995). Investigating Disease Patterns: The Science of Epidemiology. Nature Medicine. 1(12). 1318–1318. 29 indexed citations

20.

Stolley, Paul D. & Tamar Lasky. (1992). Johannes Fibiger and His Nobel Prize for the Hypothesis That a Worm Causes Stomach Cancer. Annals of Internal Medicine. 116(9). 765–769. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact